Benefit of cilostazol in patients with high risk of bleeding: subanalysis of cilostazol stroke prevention study 2.

S, Uchiyama; Y, Shinohara; Y, Katayama; T, Yamaguchi; S, Handa; K, Matsuoka; Y, Ohashi; N, Tanahashi; H, Yamamoto; C, Genka; Y, Kitagawa; H, Kusuoka; K, Nishimaru; M, Tsushima; Y, Koretsune; T, Sawada; C, Hamada

doi:10.1159/000360811

Public

Benefit of cilostazol in patients with high risk of bleeding: subanalysis of cilostazol stroke prevention study 2.

Shared by NobleBlocks on May 8, 2014 • 12:00 AM UTC

Authors:

Uchiyama S

Shinohara Y

Katayama Y

Abstract

Background The Cilostazol Stroke Prevention Study 2 (CSPS 2) showed that cilostazol significantly reduced the risk of stroke by 25.7% relative to aspirin, with significantly fewer hemorrhagic events, in patients with prior ischemic stroke, excluding cardioembolic stroke. However, whether the benefit...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!